Michelle Mitchell

• Opinion

The PM’s bold decision on tobacco will help promote good health for generations to come

Michelle Mitchell, our CEO, discusses the recent tobacco announcements and their potential impact Michelle Mitchell, our CEO, discusses the recent tobacco announcements and their potential impact

17 October 2023

• Opinion

Scotland can be a cancer research powerhouse

Michelle Mitchell, our chief executive, talks about why the charity's recent investment into research in Scotland is so important Michelle Mitchell, our chief executive, talks about why the charity's recent investment into research in Scotland is so important

21 September 2023

• Opinion

Michelle Mitchell: Cancer is a fixable problem

Our CEO Michelle Mitchell writes about how cancer care in the UK is a fixable problem, and outlines the important next steps to get to where we want to be Our CEO Michelle Mitchell writes about how cancer care in the UK is a fixable problem, and outlines the important next steps to get to where we want to be

23 May 2023

• Opinion
• Charity News

Women and girls in science: We won’t stop pushing for progress

For the International Day of Women and Girls in Science, Michelle Mitchell, CEO of Cancer Research UK, highlights some of the barriers facing women in research and how the charity is trying to overcome them. For the International Day of Women and Girls in Science, Michelle Mitchell, CEO of Cancer Research UK, highlights some of the barriers facing women in research and how the charity is trying to overcome them.

11 February 2023

• Opinion

The ‘major conditions strategy’: will ministers fail to give cancer the due care and attention it requires?

By bundling in cancer alongside other conditions via a short-term ‘major condition strategy’ will ministers fail to give cancer the due care and attention it requires? By bundling in cancer alongside other conditions via a short-term ‘major condition strategy’ will ministers fail to give cancer the due care and attention it requires?

6 February 2023

• Opinion
• Health & Medicine

The 10-year cancer plan: is improving cancer survival still a priority for this Government?  

Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer. Cancer is a fixable problem – but we need the right leadership, a robust plan and sufficient funding, writes Michelle Mitchell, our chief executive officer.

8 December 2022

• Opinion

Opinion: The Government should not be choosing between investing in staff or equipment

As the Conservative leadership campaign continues towards its finale, our next Prime Minister must make cancer a priority As the Conservative leadership campaign continues towards its finale, our next Prime Minister must make cancer a priority

27 July 2022

• Opinion

Our new strategy to make discoveries, drive progress, and bring hope

We are launching a new strategy to help us make new discoveries and bring about a world where everyone lives longer, better lives, free from the fear of cancer. We are launching a new strategy to help us make new discoveries and bring about a world where everyone lives longer, better lives, free from the fear of cancer.

17 March 2022

• Opinion
• Health & Medicine

Javid's war on cancer can't leave people behind

We’ve had plans before. What we need is leadership, commitment and competence. Addressing cancer inequalities and cancer prevention must be central to the plan. We’ve had plans before. What we need is leadership, commitment and competence. Addressing cancer inequalities and cancer prevention must be central to the plan.

4 February 2022

• Opinion

Opinion: “We’ve been pushing for change for 20 years. We’re not stopping now”

This year marks 20 years of Cancer Research UK. A chance to reflect on the incredible advances we’ve made and a reminder of how much we have left to achieve. This year marks 20 years of Cancer Research UK. A chance to reflect on the incredible advances we’ve made and a reminder of how much we have left to achieve.

24 January 2022

• Opinion
• Health & Medicine

NHS England change of chief executive – what does it mean for cancer?

Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role. Our chief executive, Michelle Mitchell, reflects on his cancer legacy and the challenges still facing Amanda Pritchard as she steps into the role.

19 August 2021

• Opinion

Turning the Life Sciences Vision into reality

The UK Government recently published their Life Sciences Vision, setting clear targets for supporting UK R&D. Cancer Research UK's CEO, Michelle Mitchell, knows that it requires real investment. The UK Government recently published their Life Sciences Vision, setting clear targets for supporting UK R&D. Cancer Research UK's CEO, Michelle Mitchell, knows that it requires real investment.

9 July 2021